Skip to main content
. 2021 Nov 27;10(23):5586. doi: 10.3390/jcm10235586
A Arthritis/arthralgia
AML Acute myeloid leukemia
ANA Antinuclear antibody
AOSD Adult-onset Still’s disease
ARDS Acute respiratory distress syndrome
C Cytolysis
CBC Complete blood count
CC Corticosteroids
CMML Chronic myelomonocytic leukemia
CPSS CMML-specific prognostic scoring system
CR Complete remission
CRP C-reactive protein
DIC Disseminated intravascular coagulation
F Female
F Fever
Fr High ferritin
G Low glycosylated ferritin
IL Interleukin
ILD interstitial lung disease
L Lymph nodes and splenomegaly
M Male
M/F Male-to-female ratio
MAS Macrophage activation syndrome
MDS Myelodysplastic syndrome
MDS MLD MDS with multilineage dysplasia
MDS SLD MDS with single lineage dysplasia
MDS-EB1 MDS with excess of blasts <5%
MDS-EB2 MDS with excess of blasts >5%
MDS-RS MDS with ring sideroblasts
MM Myelodysplastic malignancy
MTX Methotrexate
PNN Polymorphonuclear neutrophils >80%
PET scan Positron emission tomography scan
PR Partial remission
RF Rheumatoid factor
RHS Reactive hemophagocytic syndrome
R-IPPS Revised International Prognostic Scoring System
SAID Systemic autoinflammatory disorder
S Skin rash
T Sore throat
TNF Tumor necrosis factor
UBA1 Ubiquitin-like modifier activating enzyme 1
USAID Undifferentiated systemic autoinflammatory disorder
VEXAS Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic syndrome
W Leukocytosis
Yrs Years